(Q37826799)

English

Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating β-blockers

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1 reference

Europe PubMed Central

Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating β-blockers (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

arterial hypertension

0 references

0 references

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

author name string

Prakash Deedwania

1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

publication date

8 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Journal of Clinical Hypertension

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

52-59

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

beta-Blockers in hypertension: is carvedilol different?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Nonglycemic effects of insulin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Oxidative stress in insulin-resistant conditions: cardiovascular implications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

The role of renin-angiotensin system blockade in the management of hypertension associated with the cardiometabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Inflammation and insulin resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Lipid and lipoprotein dysregulation in insulin resistant states

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Nontraditional risk factors for cardiovascular disease in diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Insulin resistance and systemic hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

The vasodilatory beta-blockers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Arterial stiffness, hypertension, and rational use of nebivolol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Long term propranolol treatment and changes in body weight after myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Clinical review 26: Insulin resistance in obese and nonobese man.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Metabolic profile of nebivolol, a beta-adrenoceptor antagonist with unique characteristics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Blood pressure-lowering effect of nebivolol in hypertensive patients with type 2 diabetes mellitus: the YESTONO study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Pharmacology of combined alpha-beta-blockade. I

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Antihypertensive and metabolic effects of nifedipine and labetalol alone and in combination in primary hypertension.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Differential effects of extended-release carvedilol and extended-release metoprolol on lipid profiles in patients with hypertension: results of the Extended-Release Carvedilol Lipid Trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Antioxidant activity of carvedilol in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Vasodilating beta-adrenoceptor blockers as cardiovascular therapeutics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Nebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

New hypertension guidelines from the National Institute for Health and Clinical Excellence and the British Hypertension Society.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00386.X

21 January 2018

Identifiers

10.1111/J.1751-7176.2010.00386.X

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37826799&oldid=1729985454"